Success Metrics

Active Trials

2(50%)

Phase Distribution

Ph early_phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

4(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Not yet recruiting2

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 14 (100.0%)

Trials by Status

not_yet_recruiting250%

recruiting250%

Recent Activity

2 active trials

Showing 4 of 4

recruitingearly_phase_1

An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours

NCT06697665

not_yet_recruitingearly_phase_1

Clinical Trials (4)

Showing 4 of 4 trials

NCT06697665Early Phase 1

An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours

Recruiting

NCT05971576Early Phase 1

A Clinical Study on TILs for the Treatment of Advanced Solid Tumors

Not Yet Recruiting

NCT05971589Early Phase 1

A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors

Not Yet Recruiting

NCT05941936Early Phase 1

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Recruiting

All 4 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 4